Dr. George L. Melikian, MD

Dr. Melikian practices at Sub-Acute Care Center in Mission Hills, California.

Dr. Melikian's NPI, 1841302635, was assigned on August 31, 2006. Dr. Melikian graduated from New York Medical College in 2005. Dr. Melikian holds California license A107553.

Dr. Melikian's primary practice is Sub-Acute Care Center, at 11600a Indian Hills Road, Mission Hills, Ca 91345, Mission Hills, CA 91345 in Los Angeles County. The practice phone is (818) 898-4630. Dr. Melikian also practices at Providence Holy Cross Medical Center, 15031 W Rinaldi St, Mission Hills, CA 91345.

Dr. Melikian's primary practice is Sub-Acute Care Center in Mission Hills, California. Dr. Melikian is also affiliated with Providence Holy Cross Medical Center. The medical group on file is Facey Medical Group. Dmand AI also links Dr. Melikian to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Melikian practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Melikian's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Melikian is board certified in infectious disease by the National Board of Physicians and Surgeons. Dmand AI has Dr. Melikian's licenses on file in 2 states: California and New York.

Dmand AI lists hiv/aids and pneumonia among the conditions Dr. Melikian treats.

CMS data shows 192 Medicare services from Dr. Melikian across 4 procedure codes in 2024, for 59 Medicare patients. Medicare paid $22,323 for them.

CMS counts 59 Medicare patients who saw Dr. Melikian in 2024. The largest group is 65 to 74, with 20 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 63% are also on Medicaid. Their average risk score is 3.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Melikian's median patient age at 69, with 48% women.

In 2024, Dr. Melikian wrote 345 Medicare Part D claims for 46 patients. 53% of them were for generic drugs. CMS names the drug for 288 of them, across 15 drugs with 11 or more claims each, at $451,416 in total drug cost. In 2023, CMS named 222 claims across 12 drugs.

Dr. Melikian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Melikian, published from 2002 to 2015. 2013 was the busiest year, with 2. The most frequent topics are HIV Infections, Uganda and Vitamin A. Dr. Melikian has published most often in Antimicrob Agents Chemother. Dr. Melikian's most frequent co-authors are Walford J. Fessel, MD, Jeffrey H. Burack, MD and Edwin Dejesus, MD.

CMS Open Payments shows 38 general payments to Dr. Melikian from 12 drug and device companies from 2016 to 2024. Travel and lodging make up the largest share, 61% of the total. Pfizer Inc. paid the most, $1,709.

Dr. Melikian graduated from New York Medical College in 2005.

Dr. Melikian is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.